Altamira Therapeutics Ltd.

CYTO · NASDAQ
Analyze with AI
$0.30+$0.30 (+100%)
At close:Nov 25, 2025, 9:00 PM UTC
P/E TTM-0.02
P/B TTM0.02
P/S TTM0
Dividend Yield0%
EPS$1.82
Beta2.442
Valuation
PEG Ratio-0.00
FCF Yield-1,276.97%
EV / EBITDA-0.28
More On Valuation »
Quality
ROIC-85.68%
Gross Margin0.00%
Cash Conv. Ratio0.46
More On Quality »
Growth
Revenue 3Y CAGR-100.00%
FCF Growth-6.33%
More On Growth »
Safety
Net Debt / EBITDA0.38
Interest Coverage0.00
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00
More On Efficiency »

Altamira Therapeutics Ltd. (CYTO) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Altamira Therapeutics Ltd. (CYTO) stock price today?

As of Nov 25, 2025, 9:00 PM UTC, Altamira Therapeutics Ltd. (CYTO) stock is trading at $0.30. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CYTO stock quotes for informed trading decisions.

What is Altamira Therapeutics Ltd.'s market capitalization?

Altamira Therapeutics Ltd. (CYTO) has a market capitalization of approximately $1.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Altamira Therapeutics Ltd.'s size relative to other companies in the USD market. The market cap figure updates automatically as the CYTO stock price changes.

What is the 52-week range for Altamira Therapeutics Ltd. stock?

Altamira Therapeutics Ltd. (CYTO) stock has traded in a 52-week range of $0.30 — $0.4158. The 52-week range shows the highest and lowest prices at which CYTO traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Altamira Therapeutics Ltd. stock price to this range provides context for recent price action.

How much trading volume does Altamira Therapeutics Ltd. stock have?

Altamira Therapeutics Ltd. (CYTO) stock recently traded approximately 724.3K shares. Trading volume indicates market liquidity and investor interest in CYTO. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Altamira Therapeutics Ltd. stock.

Does Altamira Therapeutics Ltd. pay dividends to shareholders?

Yes, Altamira Therapeutics Ltd. (CYTO) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Altamira Therapeutics Ltd. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Altamira Therapeutics Ltd.'s intraday price range?

Today, Altamira Therapeutics Ltd. (CYTO) stock has traded in a range of $0.30 — $0.30. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CYTO's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Altamira Therapeutics Ltd. stock data?

AlphaPilot sources real-time CYTO stock quotes, fundamental financial data, and historical price charts for Altamira Therapeutics Ltd. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Altamira Therapeutics Ltd. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CYTO stock performance.